Artificial Intelligence for Detection and Characterisation of Bone Metastases on MRI: A Scoping Review

Background/Objectives: Bone metastasis is one of the most common manifestations of advanced malignancy and a major cause of morbidity, particularly when involving the spine. Magnetic resonance imaging (MRI) plays a central role in its detection and characterisation due to its high sensitivity for bone marrow infiltration. However, bone metastases may be missed on MRI, whilst interpretation can be time-consuming and challenging. The purpose of this study is to review and summarise the present evidence for artificial intelligence (AI) applications in the detection and classification of bone metastasis on MRI. Methods: A systematic, detailed search of the main electronic medical databases (PubMed, MEDLINE, Web of Science, and clinicaltrials.gov, last accessed on 1 January 2026) was undertaken in concordance with the PRISMA guidelines. Results: A total of 34 studies were included. AI applications were identified across several domains, including lesion detection, segmentation, disease classification, and predictive modelling. Deep learning approaches demonstrated strong performance for automated detection and segmentation, while radiomics-based models were frequently used for lesion differentiation and prediction tasks. Reported performance metrics were generally high, with area under the curve values commonly ranging from approximately 0.72–0.94, with most studies reporting AUCs exceeding 0.80 in internal validation, although substantial heterogeneity in study design, datasets, and validation strategies was observed. External validation and prospective evaluation were limited across most studies. Conclusions: Within the domain of bone metastasis, AI-based approaches have demonstrated encouraging performance and hold substantial potential to support clinical decision-making, including prognostication and prediction of treatment response. Nevertheless, further research is required to validate their clinical utility and to facilitate successful integration into routine clinical practice.

Authors

Institutions

Publication Details

Journal
Cancers
Published
2026-08-28
DOI
https://doi.org/10.3390/cancers18172794
Primary Topic
Management of metastatic bone disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Artificial Intelligence for Detection and Characterisation of Bone Metastases on MRI: A Scoping Review

Jiong Hao Tan, Ee Chin Teo, Naresh Kumar, Timothy Shao Ern Tan et al.
Cancers
Management of metastatic bone disease
article

Artificial Intelligence for Detection and Characterisation of Bone Metastases on MRI: A Scoping Review

Jiong Hao Tan, Ee Chin Teo, Naresh Kumar, Timothy Shao Ern Tan, James Thomas Patrick Decourcy Hallinan, Wilson Ong, Juncheng Huang, Gordan Toh Cheong Zheng, Aric Lee Wei Zheng
article en

Abstract

Background/Objectives: Bone metastasis is one of the most common manifestations of advanced malignancy and a major cause of morbidity, particularly when involving the spine. Magnetic resonance imaging (MRI) plays a central role in its detection and characterisation due to its high sensitivity for bone marrow infiltration. However, bone metastases may be missed on MRI, whilst interpretation can be time-consuming and challenging. The purpose of this study is to review and summarise the present evidence for artificial intelligence (AI) applications in the detection and classification of bone metastasis on MRI. Methods: A systematic, detailed search of the main electronic medical databases (PubMed, MEDLINE, Web of Science, and clinicaltrials.gov, last accessed on 1 January 2026) was undertaken in concordance with the PRISMA guidelines. Results: A total of 34 studies were included. AI applications were identified across several domains, including lesion detection, segmentation, disease classification, and predictive modelling. Deep learning approaches demonstrated strong performance for automated detection and segmentation, while radiomics-based models were frequently used for lesion differentiation and prediction tasks. Reported performance metrics were generally high, with area under the curve values commonly ranging from approximately 0.72–0.94, with most studies reporting AUCs exceeding 0.80 in internal validation, although substantial heterogeneity in study design, datasets, and validation strategies was observed. External validation and prospective evaluation were limited across most studies. Conclusions: Within the domain of bone metastasis, AI-based approaches have demonstrated encouraging performance and hold substantial potential to support clinical decision-making, including prognostication and prediction of treatment response. Nevertheless, further research is required to validate their clinical utility and to facilitate successful integration into routine clinical practice.

CancersVol. 18(17)
National University of Singapore (SG), KK Women's and Children's Hospital (SG), National University Hospital (SG), National University Health System (SG)
Peace, Justice and strong institutions
Openalex Percentile: Top 8%
Management of metastatic bone disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.